Brainstorm Cell Therapeutics Return on Net Operating Assets Trends

Brainstorm Cell Therapeutics, Inc. (BCLI)

0.58 +0.02 (+3.57%) USD | OTCM | Dec 15, 14:27

View Return on Net Operating Assets for BCLI.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	Upgrade
Theriva Biologics, Inc.	Upgrade
Oragenics, Inc.	Upgrade
NanoViricides, Inc.	Upgrade

Upgrade